Found 8 matching trials
A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users
PHASE1This single-center study will be a single-dose, randomized, double-blind, p...
Location
Vince and Associates Clinical Research, Inc.
Attention & Memory Impairments in Menopausal Women
PHASE4The purpose of this study is to determine whether a medication called Vyvan...
Location
Penn Center for Women's Behavioral Wellness
IMProving Executive Function Study
PHASE4This is a double-blind, placebo-controlled, crossover study testing whether...
Location
3535 Market Street
Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse
PHASE1This research is being done to evaluate if NRP104 is a safe drug. The other...
Location
Johns Hopkins Bayview Medical Center, Clinical Studies Program
E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy
NAThis project seeks to address cognitive disturbance, which is a frequent ad...
Location
Penn Center for Women's Behavioral Wellness
LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy
NAThis is a double-blind, placebo-controlled, study testing whether LDX impro...
Location
Penn Center for Women's Behavioral Wellness
Endocrine and Emotional Effects of Lisdexamfetamine and d-Amphetamine.
PHASE1The study will compare the acute emotional and endocrine effects of equival...
Location
University Hospital Basel
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
PHASE2This research is being done to evaluate if NRP 104 is a safe drug. The othe...
Location
Johns Hopkins Bayview Medical Center, Clinical Studies Program